z-logo
Premium
TRAF6‐mediated ubiquitination regulates nuclear translocation of NRIF, the p75 receptor interactor
Author(s) -
Geetha Thangiah,
Kenchappa Rajappa S,
Wooten Marie W,
Carter Bruce D
Publication year - 2005
Publication title -
the embo journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.484
H-Index - 392
eISSN - 1460-2075
pISSN - 0261-4189
DOI - 10.1038/sj.emboj.7600845
Subject(s) - ubiquitin , biology , ubiquitin ligase , microbiology and biotechnology , low affinity nerve growth factor receptor , nuclear localization sequence , interactor , receptor , ubiquitin protein ligases , nuclear export signal , signal transduction , nuclear protein , cytoplasm , neurotrophin , cell nucleus , genetics , transcription factor , gene
TRAF6 is an E3 ubiquitin ligase that mediates signaling from members of the tumor necrosis factor and Toll‐like receptor superfamilies, including the p75 neurotrophin receptor. Recently, TRAF6 was shown to bind to another p75 cytoplasmic interactor, NRIF, and promote its nuclear localization. Here, we demonstrate that NRIF is a substrate for TRAF6‐mediated K63 polyubiquitination and that this modification is necessary for its nuclear translocation. Activation of p75 resulted in NRIF polyubiquitination, association with TRAF6 and nuclear localization. NRIF was polyubiquitinated by TRAF6 in vitro and in cultured cells, and this was abrogated by mutation of K19 in the amino‐terminus of NRIF. The K19R mutant NRIF displayed reduced TRAF6 association and neurotrophin‐dependent nuclear localization. In neurons from traf6 −/− mice, NRIF failed to enter the nucleus in response to p75 activation, and polyubiquitination and nuclear localization were attenuated in traf6 −/− brain. Finally, unlike wild‐type NRIF, the K19R NRIF failed to reconstitute p75‐mediated apoptosis in nrif −/− neurons. These results reveal a unique mechanism of p75 signaling and a novel role for K63‐linked ubiquitin chains.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here